Numerate

  • Develops an AI platform for designing druglike compounds and optimizing leads for hard-to-treat diseases; claims a 50× to 100× improvement in efficiency compared to traditional approaches, measured by time and cost
  • Uses physical modeling, machine learning, and a variety of statistical technique...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Medable

Company Snapshot | September 24, 2021

The company was founded by James Sas, Michelle Longmire, Perry Robinson, and Tim Smith in 2015. To date, the company has raised about $202.6 million over six rounds of funding, most recently raising a Series C round in April 2021. Among its investors, we emphasize Sapphire Ventures and GSR Ventures... Not part of subscription

BrightInsight

Company Snapshot | September 24, 2021

The company was started by Benjamin Lee, Ferry Tamtoro, and Kal Patel in 2017. So far, the company has raised about $166 million in funding over three rounds, most recently raising a Series C round in March 2021. Among its investors, we highlight General Catalyst, Insight Partners, Eclipse Ventures... Not part of subscription

Amalgam Rx

Company Profile | December 13, 2021

Amalgam Rx is a developer of a software‑as‑a‑service (SaaS)‑based technology platform that enables the development, deployment, and scaling of digital therapeutics and health service applications such as electronic health record (EHR) integration, clinical decision support, and clinical trial ... To read more, click here.